Aurelion Research

Aurelion Research

Company Research

Touching Base on CLBT Following the Early 2026 SaaS Sell-Off

Cellebrite Launches Genesis, Its AI Agent, and Acquires SCG Inc.

Aurelion Research's avatar
Aurelion Research
Mar 17, 2026
∙ Paid

Our last update on CLBT was on February 3, 2026, when we discussed the SaaS sell-off that significantly impacted our favorite software company that we hold in the portfolio, Cellebrite.

CNN quoted our view and it summarizes our article well: "Analysts at Aurelion Research said they viewed the sell-off as sentiment driven based off AI uncertainty. That sentiment will likely normalize as companies see more measurable returns from AI, they said."

Since then, the sell-off has largely stabilized and indexes of tech software companies have been relatively flat. Cellebrite has rebounded slightly more, as we think other investors are starting to understand that CLBT is there to stay and should absolutely recover from this dip.

We note that the company was not highly correlated to software indexes before, slightly to Israel but mostly to its own earnings releases and specific news.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Aurelion Research · Publisher Privacy ∙ Publisher Terms
Substack · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture